Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control

Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis.

Diabetic medicine : a journal of the British Diabetic Association·2018

CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.

Oral diseases·2016

Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.

Journal of dental research·2014

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Journal of dental research·2013

Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

Journal of periodontal research·2013

A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.

Journal of periodontal research·2008

The GPCRVP score reliably predicts the impact of GLP1R human variants on receptor function.

Diabetologia·2026

Indices of obesity, malnutrition and inflammation are strong predictors of mortality in adults with type 2 diabetes: the FIELD study.

Diabetologia·2026

Hepatic PDIA5 improves hyperglycaemia and insulin resistance through stabilisation of ATF6.

Diabetologia·2026

The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Diabetologia·2026

2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes.

Diabetologia·2026

Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials.

Diabetologia·2026

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Gut microbes·2026

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine·2026

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Journal of clinical and experimental hepatology·2026

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Frontiers in microbiology·2026

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Frontiers in immunology·2026

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Medical science educator·2026

Related Experiment Videos

Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control

Related Concept Videos

Late adulthood mortality among African-American and white American people with Type 1 diabetes according to age at diabetes diagnosis.

CD36 is upregulated in mice with periodontitis and metabolic syndrome and involved in macrophage gene upregulation by palmitate.

Metabolic syndrome exacerbates inflammation and bone loss in periodontitis.

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Simvastatin inhibits lipopolysaccharide-induced osteoclastogenesis and reduces alveolar bone loss in experimental periodontal disease.

A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases.

The GPCRVP score reliably predicts the impact of GLP1R human variants on receptor function.

Indices of obesity, malnutrition and inflammation are strong predictors of mortality in adults with type 2 diabetes: the FIELD study.

Hepatic PDIA5 improves hyperglycaemia and insulin resistance through stabilisation of ATF6.

The management of type 1 diabetes in adults. The updated 2026 consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

2026 EASD evidence-based clinical practice guideline for assessing and managing diabetes distress among adults with type 1 diabetes or type 2 diabetes.

Differential physical activity responses to diabetes risk reduction interventions according to prediabetes phenotype in at-risk individuals: pooled analysis from three randomised controlled trials.

Gut microbiota: a novel key player in urinary stone formation - from oxalate metabolism to systemic regulation.

Added Value of Quadriceps Muscle Layer Thickness to modified Nutrition Risk in the Critically Ill (mNUTRIC) Score in Predicting Clinical Outcomes in Critically Ill Patients: A Prospective Observational Study.

Diabetes-associated Alterations in the Gut Microbiota-metabolite Profile of NAFLD Under Complex Clinical Conditions.

Gut microbiota-host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies.

Integrative multi-omics analysis prioritizes compartment-specific candidate targets of gut microbiota metabolites in diabetic kidney disease.

Nutriments: Integrating Patient-Centered Nutrition Education for Medical Students within a Clinical Presentation Framework.

Related Experiment Videos

Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control

Related Concept Videos

Related Articles